Accounting for 15–20% of all breast cancer cases, human epidermal growth factor receptor 2 (HER2) positive breast cancer has posed great threats to the health of women worldwide (Giaquinto et al., 2022; Harbeck et al., 2019). Here, ERBB2 is linked to breast carcinoma.